Abstract
Lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P) are bioactive lysophospholipid mediators with a wide variety of biological actions. G-protein-coupled receptors for LPA and S1P have been identified, and physiological and pathological significances of the lysophospholipids and their receptors are under intensive investigation. Furthermore, specific agonists and antagonists for the receptors have been developed for clinical applications. However, mechanisms underlying their production have not yet been fully elucidated. Recently, autotaxin, an exo-phosphodiesterase implicated in tumor cell migration, has been discovered as lysophospholipase D that produces LPA and S1P from lysophosphatidylcholine and sphingosylphosphorylcholine, respectively. In this article, I reviewed the structure, expression, substrate specificity, enzymatic function, specific inhibitors and pathophysiological significances of lysophospholipase D/autotaxin.
Keywords: Lysophospholipase D, autotoxin, lysophosphatidic acid, sphingosine 1-phosphate, lysophosphatidylcholine, sphingosylphosphorylcholine, tumor metastasis
Current Enzyme Inhibition
Title: Lysophospholipase D/Autotaxin in Lysophospholipid Biology
Volume: 3 Issue: 1
Author(s): Dong-Soon Im
Affiliation:
Keywords: Lysophospholipase D, autotoxin, lysophosphatidic acid, sphingosine 1-phosphate, lysophosphatidylcholine, sphingosylphosphorylcholine, tumor metastasis
Abstract: Lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P) are bioactive lysophospholipid mediators with a wide variety of biological actions. G-protein-coupled receptors for LPA and S1P have been identified, and physiological and pathological significances of the lysophospholipids and their receptors are under intensive investigation. Furthermore, specific agonists and antagonists for the receptors have been developed for clinical applications. However, mechanisms underlying their production have not yet been fully elucidated. Recently, autotaxin, an exo-phosphodiesterase implicated in tumor cell migration, has been discovered as lysophospholipase D that produces LPA and S1P from lysophosphatidylcholine and sphingosylphosphorylcholine, respectively. In this article, I reviewed the structure, expression, substrate specificity, enzymatic function, specific inhibitors and pathophysiological significances of lysophospholipase D/autotaxin.
Export Options
About this article
Cite this article as:
Im Dong-Soon, Lysophospholipase D/Autotaxin in Lysophospholipid Biology, Current Enzyme Inhibition 2007; 3 (1) . https://dx.doi.org/10.2174/157340807779815440
DOI https://dx.doi.org/10.2174/157340807779815440 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
MicroRNA-183 Functions As an Oncogene by Regulating PDCD4 in Gastric Cancer
Anti-Cancer Agents in Medicinal Chemistry Chelating Agents for Metal Intoxication
Current Medicinal Chemistry Antagonists of Growth Hormone-Releasing Hormone in Oncology
Combinatorial Chemistry & High Throughput Screening Painting the Target Around the Arrow: Two-Step Prodrug Therapies from a Carbohydrate Chemists Perspective
Current Drug Delivery Linezolid Activity Against Disseminated Listeria monocytogenes Meningitis and Central Nervous System Abscesses: Focus on Early Drug Myelotoxicity
Current Drug Safety Combination Platinum-based and DNA Damage Response-targeting Cancer Therapy: Evolution and Future Directions
Current Medicinal Chemistry pH-Sensitive PEGylated Liposomes Functionalized With a Fibronectin-Mimetic Peptide Show Enhanced Intracellular Delivery to Colon Cancer Cells
Current Pharmaceutical Biotechnology Review of Procedures Used for the Extraction of Anti-Cancer Compounds from Tropical Plants
Anti-Cancer Agents in Medicinal Chemistry Anticancer Mammalian Target of Rapamycin (mTOR) Signaling Pathway Inhibitors: Current Status, Challenges and Future Prospects in Management of Epilepsy
CNS & Neurological Disorders - Drug Targets A New Frontier in the Treatment of Cancer: NK-1 Receptor Antagonists
Current Medicinal Chemistry Recent Advances in the Discovery of Novel HSP90 Inhibitors: An Update from 2014
Current Drug Targets Novel Therapeutic Approaches Targeting Vascular Endothelial Growth Factor and its Receptors in Haematological Malignancies
Current Cancer Drug Targets Targeting the Epidermal Growth Factor Pathway as Therapy for Glioblastoma
Current Cancer Therapy Reviews Tribbles-Related Protein Family Members as Regulators or Substrates of the Ubiquitin-Proteasome System in Cancer Development
Current Cancer Drug Targets CNS Drug Development – Lost in Translation?
Mini-Reviews in Medicinal Chemistry Reviewing Colchicaceae Alkaloids – Perspectives of Evolution on Medicinal Chemistry
Current Topics in Medicinal Chemistry Recent Progress of Small Molecular VEGFR Inhibitors as Anticancer Agents
Mini-Reviews in Medicinal Chemistry Meet Our Section Editor
CNS & Neurological Disorders - Drug Targets The Mechanisms of Anticancer Agents by Genistein and Synthetic Derivatives of Isoflavone
Mini-Reviews in Medicinal Chemistry Glucocorticoid Receptors and Bone
Current Pharmaceutical Design